CNS Pharmaceuticals reported cash from operations of -$3.05M and free cash flow of -$3.05M for the quarter ended Dec 2025, up 44.2% year over year. This cash flow statement covers 30 quarters of results from Sep 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||
| Net Income | -3.61M | -3.81M | -3.81M | -3.25M | -3.15M | -3.57M | -3.42M | -5.14M | -4.93M | -4.02M | -4.52M | -5.38M | -3.54M | -2.53M | -5.61M | -3.18M | -4.30M | -2.37M | -3.22M | -5.96M | ||||||||||
| Depreciation and DepletionDep. & Depletion | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 899.00 | 953.00 | 818.00 | 752.00 | 751.00 | 985.00 | 0.00M | 0.00M | 697.00 | 0.00M | ||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.01M | |||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 899.00 | 953.00 | 818.00 | 752.00 | 751.00 | 985.00 | 0.00M | 0.00M | 697.00 | 0.00M | ||||||||||
| Share-based CompensationStock Comp. | 0.43M | 0.47M | 0.51M | 0.32M | 0.34M | 0.29M | 0.29M | 0.29M | 0.29M | 0.29M | 0.19M | 0.23M | 0.20M | 0.23M | 0.27M | 0.13M | 0.06M | 0.02M | 0.02M | 0.09M | ||||||||||
| Gains from Sales and DivestituresGains Divest | 0.00M | -476.00 | -757.00 | 259.00 | 190.00 | 0.00M | ||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.11M | -0.17M | 0.57M | 0.52M | -0.67M | 0.00M | 0.15M | 2.22M | -0.90M | 0.79M | ||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.02M | 0.23M | 0.14M | -0.68M | 0.08M | -0.03M | -0.23M | 2.48M | -0.88M | 0.20M | 0.20M | 1.81M | 0.05M | 0.76M | -2.61M | -1.83M | 0.37M | -1.31M | 0.67M | 1.81M | ||||||||||
| Change in Other Operating AssetsOther Assets Change | 0.25M | 1.72M | -0.60M | 0.15M | -0.32M | 0.06M | -0.88M | 0.27M | -0.69M | -0.13M | -0.75M | -0.80M | -0.10M | 0.12M | -0.55M | 0.60M | -0.62M | 1.68M | -0.36M | -1.01M | ||||||||||
| Other Working Capital ChangesOther WC Changes | -0.25M | -1.72M | 0.60M | -0.15M | 0.32M | -0.06M | 0.88M | -0.27M | 0.69M | 0.13M | 0.75M | 0.80M | 0.10M | -0.12M | 0.55M | -0.60M | 0.62M | -1.68M | 0.36M | 1.01M | ||||||||||
| Cash from OperationsCash from Ops. | -3.31M | -5.00M | -2.00M | -3.24M | -3.08M | -3.36M | -1.81M | -2.31M | -4.82M | -3.40M | -3.38M | -2.54M | -3.19M | -1.65M | -6.80M | -5.47M | -3.24M | -5.34M | -2.17M | -3.05M | ||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.00M | 0.00M | 0.00M | 0.00M | -1.00 | 0.00M | 0.00M | 0.00M | ||||||||||||||||||||||
| Change in Property, Plant and EquipmentChange in PP&E | 0.00M | 0.00M | 0.00M | 0.00M | 1.00 | 0.00M | 0.00M | 0.00M | ||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 0.00M | 0.00M | 0.00M | 0.00M | 1.00 | 0.00M | 0.00M | 0.00M | ||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||
| Long-Term Debt RepaymentsLT Debt Repayment | 0.13M | 0.13M | 0.13M | 0.08M | 0.12M | 0.12M | 0.12M | 0.08M | 0.12M | 0.12M | 0.12M | 0.07M | 0.09M | 0.09M | 0.09M | 0.03M | 0.09M | 0.09M | 0.09M | 0.03M | ||||||||||
| Non-Current Debt | -0.13M | -0.13M | -0.13M | -0.08M | -0.12M | -0.12M | -0.12M | -0.08M | -0.12M | -0.12M | -0.12M | -0.07M | -0.09M | -0.09M | -0.09M | -0.03M | -0.09M | -0.09M | -0.09M | -0.03M | ||||||||||
| Net Debt Issuances and RepaymentsNet Debt Issuance | -0.13M | -0.13M | -0.13M | -0.08M | -0.12M | -0.12M | -0.12M | -0.08M | -0.12M | -0.12M | -0.12M | -0.07M | -0.09M | -0.09M | -0.09M | -0.03M | -0.09M | -0.09M | -0.09M | -0.03M | ||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||
| Common Stock IssuedStock Issued | 0.48M | 0.94M | 3.57M | 10.63M | 5.41M | 609.00 | 2.69M | 0.13M | 2.45M | 3.55M | 2.43M | 12.41M | 5.00M | 9.92M | -9.03M | 13.55M | 0.50M | |||||||||||||
| Shares Repurchased | 0.20M | 0.04M | 0.01M | 0.06M | ||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.48M | 0.94M | 3.57M | 10.63M | 5.41M | 609.00 | 2.69M | 0.13M | 2.25M | 3.55M | 2.43M | 12.37M | 4.99M | 9.92M | -9.03M | 13.55M | 0.44M | |||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.48M | 0.94M | 3.57M | 10.63M | 5.41M | 609.00 | 2.69M | 0.13M | 2.25M | 3.55M | 2.43M | 12.37M | 4.99M | 9.92M | -9.03M | 13.55M | 0.44M | |||||||||||||
| Other financing activitiesOther financing | -557.00 | 0.00M | ||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.35M | 0.81M | 3.44M | -0.08M | 10.51M | -0.12M | -0.12M | 5.33M | -0.12M | 2.57M | 0.01M | 2.18M | 3.46M | 2.33M | 12.28M | 4.96M | 9.83M | 4.43M | -0.09M | 0.41M | ||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| Change in Cash | -2.96M | -4.19M | 1.44M | -3.32M | 7.44M | -3.48M | -1.93M | 3.03M | -4.94M | -0.83M | -3.37M | -0.36M | 0.27M | 0.68M | 5.48M | -0.51M | 6.59M | -0.92M | -2.27M | -2.66M | ||||||||||
| Ending Cash Balance | 11.08M | 6.89M | 8.33M | 5.00M | 12.44M | 8.96M | 7.03M | 10.06M | 5.11M | 4.28M | 0.91M | 0.55M | 0.82M | 1.49M | 6.97M | 6.46M | 13.05M | 12.13M | 9.86M | 7.20M | ||||||||||
| Free Cash FlowFCF | -3.31M | -5.00M | -2.00M | -3.24M | -3.08M | -3.37M | -1.81M | -2.31M | -4.82M | -3.40M | -3.38M | -2.54M | -3.19M | -1.65M | -6.80M | -5.48M | -3.24M | -5.34M | -2.17M | -3.05M | ||||||||||
| Net Cash FlowNCF | -2.96M | -4.19M | 1.44M | -3.32M | 7.44M | -3.48M | -1.93M | 3.03M | -4.94M | -0.83M | -3.37M | -0.36M | 0.27M | 0.68M | 5.48M | -0.51M | 6.59M | -0.92M | -2.27M | -2.64M | ||||||||||
| Interest Paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 969.00 | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 253.00 | 0.01M | 0.00M | 0.00M | 0.00M |
Pull CNS Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CNSP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CNSP", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CNSP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();